Immunotherapy Drug Durvalumab Getting Support for Phase 3 Mesothelioma Study
By: Devin Golden
May 28, 2020
Immunotherapy likely will be a standard treatment for mesothelioma in the future. The lingering question is how long we have to wait for the first drug to receive FDA...
Read Post